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DatabasesThe National Cancer Institute (NCI) Cancer Biomedical Informatics Grid (caBIG) program established
standards and best practices for biorepository data management by creating an infrastructure to propa-
gate biospecimen resource sharing while maintaining data integrity and security. caTissue Suite, a
biospecimen data management software tool, has evolved from this effort. More recently, the caTissue
Suite continues to evolve as an open source initiative known as OpenSpecimen. The essential functional-
ity of OpenSpecimen includes the capture and representation of highly granular, hierarchically-
structured data for biospecimen processing, quality assurance, tracking, and annotation. Ideal for
multi-user and multi-site biorepository environments, OpenSpecimen permits role-based access to speci-
fic sets of data operations through a user-interface designed to accommodate varying workflows and
unique user needs. The software is interoperable, both syntactically and semantically, with an array of
other bioinformatics tools given its integration of standard vocabularies thus enabling research involving
biospecimens. End-users are encouraged to share their day-to-day experiences in working with the appli-
cation, thus providing to the community board insight into the needs and limitations which need be
addressed. Users are also requested to review and validate new features through group testing environ-
ments and mock screens. Through this user interaction, application flexibility and interoperability have
been recognized as necessary developmental focuses essential for accommodating diverse adoption sce-
narios and biobanking workflows to catalyze advances in biomedical research and operations. Given the
diversity of biobanking practices and workforce roles, efforts have been made consistently to maintain
robust data granularity while aiding user accessibility, data discoverability, and security within and
across applications by providing a lower learning curve in using OpenSpecimen. Iterative development
and testing cycles provide continuous maintenance and up-to-date capabilities for this freely available,
open-access, web-based software application that is globally-adopted at over 25 institutions.
 2015 Elsevier Inc. All rights reserved.1. Background and significance
Resources for collecting, processing, storing, and tracking
human biospecimens are vital to advances in molecular technolo-
gies, sophisticated clinical trial design, personalized medicine, and
collaborative research [1]. Repositories at cancer and academic
health centers collect and distribute diverse human biospecimens
for molecular and genomic studies utilizing a wide variety of tech-
nology platforms [2]; thus to accommodate the evolving functionalcomplexity of biospecimen resources, an informatics system is
required [3]. However, many biospecimen resource centers have
limitations, including: ad hoc, inadequate, or closed-source
biospecimen banking/tracking informatics systems; large, sophisti-
cated legacy systems that lack semantic and syntactic interoper-
ability; and, non-modular informatics systems that cannot easily
accommodate the expanding functionality of biospecimen
resource centers [4]. Moreover, there is a need for different user
classes (i.e. scientists, clinicians, biospecimen bank personnel) to
access specific data types based upon their unique responsibilities.
Though biospecimen resource centers have common functionality,
each may have a unique workflow, levels of hierarchical data gran-
ularity, and end-user requirements [1,3].
Appreciating these deficits and the significance of biospecimens
in research, the National Cancer Institute (NCI) formed standards
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tructure to propagate resource sharing while maintaining data
integrity and security [5]. Toward this effort, the NCI constructed
the Office of Biorepositories and Biospecimen Research (OBBR) in
2005 to: ‘‘(i) Serve as the coordination and management center
for biospecimen-related policies, practices, and other related issues
across the NCI’s biorepositories; and, (ii) Provide leadership for
biobanking activities supporting all types of cancer research
funded by the NCI [6]. While the OBBR developed the best practices
directives, NCI also realized meeting the functional needs of the
biospecimen resource community would require the development
of informatics tools. For this, the NCI established the cancer
Biomedical Informatics Grid (caBIG) program, aimed at develop-
ing an open source, open access information technology infrastruc-
ture with a network of physicians, researchers, and patients within
the cancer community [7].
Guided by the Tissue Banks and Pathology Tools (TBPT) work-
space, the OBBR guidelines, the caBIG community, and the caGRID
infrastructure [8], researchers at seven institutions developed a
database application for biospecimen management, caTissue Core.
Two additional applications were built to meet natural language
processing and clinical data annotation needs: (i) The Cancer Text
Information Extraction System (caTIES) automated coding, de-
identifying, storing, and retrieving data from free-text pathology
reports; and (ii) The Clinical Annotation Engine (CAE) provided a
web-based user-interface for standards-based manual annotation
of biospecimens with clinical information. Since its initial concep-
tion, the caTissue project has evolved from this set of three comple-
mentary software applications into a comprehensive biospecimen
informationmanagement system that has been adopted worldwide
by cancer centers, academic and commercial entities and continues
to be developed by the biospecimen informatics community [9].
The caTissue Suite application has grown throughout multiple
developmental releases based on NCI directives and the biospeci-
men user community input. Due to a shift from NCI-supported
development to an open-source model of funding and develop-
ment, caTissue underwent a community-elected name change to
OpenSpecimen in September 2014 [10]. The development efforts
of caTissue Suite and nowOpenSpecimen represent how accommo-
dating the evolving functional complexity of biospecimen data and
biobanking workflows can be effectively accomplished through an
informatics system – one that leverages the varying needs of the
biobanking community. To facilitate integration across other appli-
cations (e.g., clinical data management systems) and workflows,
the informatics tool needs a capacity for interoperative flexibility.
The caTissue/OpenSpecimen development trajectory described in
this manuscript reveals how the support, effectiveness, and propa-
gation of such an application may be desirably enhanced when
development efforts evolve with input from the community of
users, is freely available, and is customizable.
Objectives
The OpenSpecimen project provides a fundamental and extensi-
ble system design allowing researchers to comprehensively, elec-
tronically record and search for biospecimen data related to
clinical and pathologic parameters across multiple biospecimen
resources using a seamless and secure user-interface. The specific
requirements for developing OpenSpecimen, guided by community
users, include: using data element standards to develop an infor-
matics system for biospecimen data storage, processing, quality
assurance, tracking, and annotation; having the ability to store
complex and hierarchical biospecimen tracking data with high
granularity; creating a user-interface to accommodate varying
workflows present at diverse biospecimen resource centers;
allowing alternate functionality for specific user classes for rapiddeployment at any biospecimen resource center; and the means
to electronically interoperate with other informatics systems via
an Application Program Interface (API). Most importantly, wider
adoption and feedback with the biospecimen user community –
through monthly calls, annual meetings, and on-line forums com-
prised of over 40 adopters across United States of America, Europe,
Australia, Canada, Africa, and the Middle East – allow new
enhancements to be developed and incorporated to create the lat-
est release of OpenSpecimen. Thus, the product consumers drive
the informatics tool development.2. Materials and methods
2.1. Architecture
The architecture is that of a modern web-based application
where each tier is optimized for speed, reliability and data integ-
rity. This structure supports both application business and usabil-
ity cases developed by the NCI and the greater biospecimen user
community. OpenSpecimen comprises an n-tiered architecture:
(i) Client Layer consists of both a web-based UI and API containing
HTML and JAVA applications passing data objects. These applica-
tions request operations on the server side. The Web browser
and API are two client programs in OpenSpecimen application,
(ii) Presentation Layer provides a web interface, as well as support
for the API. The Presentation Layer comprises a web server with a
Struts Framework, ActionServlet, ActionForm, Action, JSP Engine
and Tiles Engine, (iii) Object Layer is the heart of the application
and contains domain objects, model classes, and the data access
layer. The Object Layer fulfills all tissue banking related business
requirements. In the Object Layer, Domain Objects are passed to
a Data Access Object. (iv) Data Sources is the backend of the appli-
cation and is a local database that stores all the tissue banking
information. Hibernate and JDBC pass information to the database.
Fig. 1 depicts the n-tiered architecture described above.
2.1.1. Technical specifications
The software stack has been updated and can run on modern
operating systems using proven, current technologies. The busi-
ness logic is written in Java/J2EE, while the interaction with the
database is performed using either Hibernate or JDBC based on
expected performance requirements. Hibernate is used in cases
where Java objects are to be inserted/updated in the database. JDBC
is used in cases like the query interface where high throughput
queries can be expected. The user interface is developed using
JSP, JavaScript, Flex, and Ajax technologies. The Security infrastruc-
ture is built using the NCI CBIIT’s Common Security Module (CSM).
The application program interface (API), to read and write data, is
developed using the caCORE SDK toolkit with additional
OpenSpecimen specific enhancements. Sharing of data on caGrid
using caGrid Query Language (CQL) is also supported. OpenSpeci-
men installation is a command-line based process built using
ANT scripts. The technology stack for latest OpenSpecimen is com-
prised of Apache 2.2, JBoss 5.1.0 GA, Ant 1.7.1, JDK 1.6, Windows or
Linux server, and MySQL 5.1.x or Oracle 10 g or Oracle 11 g, and is
compatible with Internet Explorer 11, Mozilla Firefox 38, and Safari
7. Hardware requirements include a least 4 GB of RAM, 100 GB
HDD, and Server class CPU. Additionally, OpenSpecimen is easily
portable to other non-supported database (e.g., PostgreSQL or MS
SQL), web server (e.g., Microsoft IIS) or browser with some minor
coding adjustments.
2.1.2. Development
Two criteria are essential for enabling collaborators to share
data: a transportation mechanism and understanding. To meet
Fig. 1. Diagrammatic representation of OpenSpecimen architecture.
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Cancer Institute Center for Bioinformatics (NCICB) developed a
cancer Common Ontologic Representation Environment (caCORE).
Systems built using the caCORE paradigm, like OpenSpecimen,
address two aspects of interoperability: the ability to access data
(syntactic interoperability) and the ability to understand the data
once retrieved (semantic interoperability) as described below. For
further information concerning OpenSpecimen’s development
approach; testing methodology; programmatic access using
caCORE, API, and caGrid; and security management refer to the
resources listed in the bibliography and Appendix A [11–13].2.1.3. Data model
OpenSpecimen is primarily modeled using the Unified Model-
ing Language (UML) with well-represented application semantics
through a logical model in UML. The object model provides a
description of object-oriented classes, attributes, associations,
and eXtensible Markup Language (XML) tags. Due to adjustments
in the OpenSpecimen database structure to preserve efficiency
throughout iterative developments, a direct mapping between
entity classes within the model to elements within database tables
may present minor differences. However, the classes in the model
conceptually represent database elements and such a mapping can
be easily inferred. The OpenSpecimen data model follows the
caCORE Software Development Kit (SDK) guidelines for naming
classes, attributes, and associations. To facilitate semantic interop-
erability, OpenSpecimen data elements are annotated with stan-
dard vocabulary (NCI Metathesaurus) concepts and stored in the
Cancer Data Standards Registry and Repository (caDSR).2.1.4. Database access and audit trail
Database access is achieved via the Data Access Object (DAO)
layer. The DAO layer separates the business logic with the database
interactions. The DAO layer also performs an audit of every opera-
tion including storing the user’s identifier, Identity Protocol
address, timestamp, old value and new value of every data change.3. Results
Since the inception of caTissue in 2005 to its current status as
OpenSpecimen, it has been designed as a generic, standardized,
open-source system providing comprehensive functionality to
track and annotate specimens and to search for biospecimens of
interest for correlative science studies. As biobanking needs pro-
gressed, necessary enhancements to caTissue were identified and
developed, and this practice continues in OpenSpecimen. Keyfeatures and functionalities; integration with other systems; and
recent enhancements in OpenSpecimen are described below.3.1. Features and functionalities
Similar to many software development projects, there is a bal-
ance between meeting all end-user needs and making the software
user-friendly. For electronic systems that support repository oper-
ational workflows, in general, we have learned it is of upmost sig-
nificance that features around administration, privileges and
security, data entry, and query be maximized for performance
and usability. Systems that blend interoperability with ease of
use will be accepted over ones that tend to favor either.
The features and functionalities described in this section are
seen as essential to the biospecimen user community for facilitated
workflow and research. Entry, interoperative distribution, tracking,
and procurement of biospecimen data throughout OpenSpecimen
is streamlined and secured by integrating unique capabilities
within the administrative functions, data annotation, and access
privileges.3.1.1. Administrative features and functions
Managing biospecimen data robustly requires diverse features
and functionalities, including:3.1.1.1. Core data elements. The fundamental workflow involves
tracking multiple biospecimens from the same patient or partici-
pant, creating and tracking refined materials (RNA, DNA, etc.) used
for molecular analysis, and distributing biospecimens. The core
data elements involved in managing the workflow are defined in
Table 1.3.1.1.2. Storage containers. A storage container represents a physi-
cally discrete object used to store biospecimens, specimen arrays,
or other containers. OpenSpecimen utilizes flexible and hierarchi-
cal storage representation to display biospecimen locations. More-
over, users can employ a storage type template during the creation
of a new storage container, thus maintaining conformity among
similar containers. Guidelines for storage containers make the stor-
age system more organized, particularly when banking samples
divided and stored by biospecimen type. For example, a storage
container can be restricted to hold samples of a certain class (e.g.
tissue, fluid, cell, or molecular) or type (e.g. fixed tissue, serum, cell
pellet, DNA) and biospecimens procured under certain collection
protocols.
Table 1
Data elements used in OpenSpecimen.
Data element Description
Participant Participant is not necessarily a patient.
Participant is an individual from whom
biospecimens are collected for research
purposes
Participant Registration Participants registered to a research study
(collection Protocol) for collection of clinical
and biospecimen information
Specimen Collection Group A group of one or more biospecimens
collected at a single point in time from a
Participant registered to a research study.
Typically referred to as a case or accession in
anatomic pathology and as an encounter
event in a clinical study or trial
Specimen A circumscribed piece of tissue or body fluid
collected from a Participant at a particular
point in time
Specimen Events/Procedures Any action performed on a biospecimen is
referred to as an event/procedure. (e.
g.transfer, review of the biospecimen, freeze,
thaw, fixed, disposal, spun)
Specimen Array A collection of biospecimens arranged in an
ordered pattern (e.g. a 96 well PCR plate)
Storage Container A physically discrete container used to store a
biospecimen (e.g. freezer, shelf, rack, and box)
Distribution The act of distributing, spreading, or
apportioning based on a set of written
procedures describing what, how many, and
how much of a biospecimen or biospecimens
will be utilized for research. Biospecimens
may be collected under one collection
protocol and then later utilized by single or
multiple studies
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tains a set of guidelines delineating what, how, and when biospec-
imens are to be collected; hence, a CP contains the biospecimen
collection schedule for all registered participants. Creating a CP
provides the ability to define consent questions, time points, and
biospecimen collected per time point, in addition to defining future
derivatives and aliquots created from the collected biospecimens.
The OpenSpecimen system uses this information to create antici-
pated biospecimens for each participant registration and builds a
study calendar based on the anticipated biospecimens. This infor-
mation can be used to predict workload for a specified future time
period and generate missing biospecimen reports by querying for
biospecimens past their anticipated collection date. Additionally,
there is support for complex protocols such as studies with arms
and phases.
3.1.1.4. Biospecimen data entry. Data captured are categorized in
three ways: (a) clinical data, (b) pathology data and reports, and,
(c) quality assurance and availability data. Clinical data are repre-
sented as participants, collection protocols, and participant proto-
col identifier (PPI). The participant protocol identifier (PPI) is the
study number assigned to each participant, uniquely identifying
each person and their biospecimens in each study.
3.1.1.5. Data entry workflows. Biorepositories operate in diverse
ways; thus, designing a single data management system is chal-
lenging. To account for multiple manual data entry scenarios,
workflows are generalized so adopters can modify biorepository
processes to create the most befitting environment. Biorepository
staff can process biospecimens individually or in bulk, both meth-
ods requiring user action (e.g. add biospecimen events, transfer,
distribute). The Bulk Operations functionality allows multiple
biospecimen data to be loaded in aggregate rather than via a singlerecord within the traditional data entry interface, thereby signifi-
cantly decreasing data entry time. This function is akin to using a
comma delimited file to load large amounts of data directly to a
database. Users can download common ‘data templates’ that are
available within the application. Data can then be pasted into the
template and subsequently uploaded into OpenSpecimen. This fea-
ture can also be used for one-time loading of legacy data from sim-
ple spreadsheets or other data sources.
3.1.1.6. Specimen collection group (SCG). Specimen collection groups
(or time points) are regimented checkpoints throughout a clinical
study during which specified biospecimen(s) are collected from a
participant. Within the SCG are the biospecimens themselves
(e.g. paraffin blocks, serum, plasma, frozen tissue) from which
other biospecimens can be derived (e.g. whole blood to plasma)
or aliquoted (e.g. four vials of plasma).
3.1.1.7. Distribution protocol (DP). The research study itself is a dis-
tribution protocol. Items registered in the DP include IRB number
or exempt status, the principal investigator (PI), study title, and
other standard study information. While the primary function of
the DP allows the biospecimen resource staff to associate biospec-
imens with studies analyzing those specimens, the DP information
is searchable by the research scientist. One can query data associ-
ated with the participant, pathology data associated with the SCG,
and quality assurance and availability data associated with individ-
ual biospecimen.
3.1.1.8. Label/barcode generation and printing. OpenSpecimen
allows customized generation of labels and barcode for biospeci-
mens. The contents of the label can be configured at the collection
protocol level. Multiple barcode printers can be configured and
OpenSpecimen can be configured to print on different types of
labels (caps, slides, tubes), thus, enabling the essential feature of
biospecimen tracking.
3.1.2. Data annotation features
Rich data annotation capabilities for informed consent status,
clinical data (e.g. treatment, follow-up events), pathology data
(based on College of American Pathologists organ site checklists)
[14], and textual pathology reports for the study participant and
biospecimens allow for robust biospecimen data collection. Default
clinical annotations were deemed necessary at three levels: Partic-
ipant, Specimen Collection Group, and Specimen (Table 2). Stan-
dard vocabularies (e.g., ICD9, LOINC, RxNorm) are used for
enumerated data elements, modeled in UML and imported in the
software.
The ability to extend the application, known as Dynamic Exten-
sion/Clinical Annotations, is available to modify OpenSpecimen in
order to meet study-specific requirements. This functionality per-
mits data entry forms to be created on-the-fly to support annotat-
ing biospecimens or capturing additional clinical data. This allows
different clinical domains (e.g. cancer vs. cardiovascular disease) to
have tailored data collection within OpenSpecimen without spe-
cialized programming. For example, with the correct permissions,
a user could electronically mimic a study case report form or create
a new form to capture specimen biomarker testing results. With
the OpenSpecimen Graphical User-interface (GUI), users can create
forms by adding controls (e.g. text box, drop down), data validation
rules, and other attributes for custom data. The forms can then be
added to annotate a participant, specimen collection group, or
specimen as appropriate.
3.1.3. Role-based access privileges
OpenSpecimen serves two key user groups: (i) biorepository
resource staff tracking and storing data about their biospecimen
Table 2
Clinical annotations in OpenSpecimen.
Participant Specimen Collection Group Biospecimen
Laboratory Tests Solid Tissue Pathology Solid Tissue Pathology
Family History Hematology Pathology Colorectal Specimen Pathology
Treatment/Treatment Regimen Pancreas Pathology Pancreas Specimen Pathology
Radiation Therapy Prostate Needle Biopsy Pathology Melanoma Specimen Pathology
Chemotherapy CNS Pathology CNS Specimen Pathology
Environmental Exposures Transurethral Prostate Resection Pathology Prostate Specimen Pathology
Alcohol Use Melanoma Pathology Kidney Specimen Pathology
Tobacco Use Lung Biopsy Pathology Lung Specimen Pathology
Health Examination Lung Resection Pathology Breast Specimen Pathology
New Diagnosis Kidney Biopsy Pathology




Colorectal Local Excision Pathology
Colorectal Excisional Biopsy Pathology
Colorectal Resection Pathology
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searching for biospecimens and associated data for translational
research projects and requesting qualifying biospecimens for fur-
ther study.3.1.3.1. Roles. Users are assigned a ‘built-in’ role such as an admin-
istrator, supervisor, technician, or scientist, designating distinct
permissions for data access (Table 3). The roles are customizable
by adding or removing privileges based on the required activity.
Access is controlled with individual user-group assigned privi-
leges further controlled at the object, record, and attribute levels
and defined within independent biospecimen repository sites.
Moreover, role-based access allows individual users to have
assigned privileges based upon their affiliation with an individual
biorepository or their involvement in a particular collection proto-
col (study), independent of actual physical location. Hence, users at
different institutions involved in the same study can have the same
privileges assigned.Fig. 2. Biospecimen repositories are logically separate entities.3.1.3.2. Acquiring and sharing data and biospecimen. Physical
biospecimen repositories are represented as logically separated
entities generating optimized user experiences based on the
assigned role (Fig. 2). Users can create and save custom parameter-
ized queries to view and export specific sets of data filtered for par-
ticipant privacy in compliance with HIPAA guidelines and based on
user privileges (Fig. 3(A)–(C)).Table 3
User roles in OpenSpecimen.
Role Description
Super Administrator A Super Administrator can perform any
operation within the application
Administrator An Administrator registers new users,
containers, and collection protocols and
distribution protocols into the system,
typically within a single physical biorepository
Supervisor A Supervisor adds participants and registers
them to collection protocols
Technician A Technician adds biospecimens into the
system
Scientist A Scientist performs a query and orders
biospecimens and biospecimen arrays of
interest
Custom The Custom role allows selected privileges to
be assigned to a userOpenSpecimen permits a scientist to query for biospecimens of
interest and, when needed, place orders for those biospecimens or
biospecimen arrays. Biorepository staff can view the order list, pro-
cess the distribution, and generate a report, which can be exported
in a comma-delimited format to use for analyses and integration
with billing or other informatics tools. Participant consent
responses, if recorded in the application, are displayed for the user
to confirm prior to distribution (Fig. 4). Users can then send and
receive biospecimens from one site to another via the built-in ship-
ping and tracking functionality. The biospecimens are placed in an
electronic shipment, with a unique shipment identifier and bar-
code. The system tracks the shipments’ movement between the
sites and sends email notifications to appropriate personnel during
the processing cycle (e.g. order, in-transit, receipt).3.2. Integration with other systems
OpenSpecimen’s capability to integrate with other systems
facilitates biorepository operations such as billing or regulatory
compliance (e.g. audit or QA data) in addition to methods
in biospecimen research (e.g., phenotype-genotype studies).
Fig. 3. Users create and save parameterized queries (A); hence, queries can be reused by altering selected attributes (B). Results are presented and available to export (C)
based on participant consent and user privileges.
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OpenSpecimen API. As previously referenced, caCORE compliant
systems achieve syntactic and semantic interoperability, while
non-caCORE compliant external systems can write and read data
from OpenSpecimen but may lose semantics. Surgical pathology
reports can be imported, and the system can create or program-
matically match to participants in OpenSpecimen using the Mirth
Connect, which queues HL7 messages to load the reports [15].
To facilitate data interoperability, a Clinical Data Management
System (CDMS) storing study participant clinical data can be used
to populate participant demographics and extract biospecimen
details. For example, ClinPortal, a custom CDMS developed by
Washington University School of Medicine, is integrated with
OpenSpecimen in both the application presentation and data
layers. Via this integration, users may seamlessly traverse bothapplications with a single account, entering and accessing partici-
pant specific clinical study data and biospecimen data.
Research patient data warehouses can likewise extract data
from OpenSpecimen to give the research-scientist access to inpa-
tient and outpatient data along with corresponding biospecimens
thus facilitating rapid application of advances in science to
improvements in patient care.
The OpenClinica and EPIC applications support participant reg-
istration to clinical studies within OpenSpecimen. Both of these
applications are separate from, yet interoperable with OpenSpeci-
men. To facilitate integration across clinical trial and biorepository
systems and workflows, a participant registered in OpenClinica
should automatically be registered in the corresponding Collection
Protocol in OpenSpecimen. In the EPIC integration, subjects are
registered to studies through the EPIC web interface, and EPIC
Fig. 4. Consent Tiers tracks the specific participant permissions for sharing of the biospecimen in current and future research.
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the participant. For clinical trials containing a biospecimen collec-
tion component, studies in OpenClinica link to collection protocols
in OpenSpecimen through the SHMi hub (Secure HL7 Mirth Inter-
face Interface), a toolkit specifically developed to integrate various
applications with OpenSpecimen via HL7 messaging. SHMi is the
messaging Hub that receives and sends messages between
OpenClinica, EPIC, and OpenSpecimen [16,17]. When a subject is
registered or updated in EPIC or OpenClinica, the registration or
notification of a change to the participant’s data is broadcasted
through SHMi hub to OpenSpecimen and the participant is regis-
tered to the associated collection protocol. When a patient is regis-
tered to a study, the message conveys the consent, signature date,
and registration date. OpenSpecimen interoperates with both EPIC
and OpenClinica in a number of different scenarios including:
becoming aware of certain initiated events; obtaining data related
to the aforementioned events; and executing its own workflow on
the data obtained.
3.3. Enhancements to address lessons learned
Throughout the development of caTissue and OpenSpecimen,
efforts have been made consistently to maintain robust granularity
within the structure of the data while easing the access to the
information. A key example of a lesson learned pertains to difficul-
ties in query construction. Originally, query development needed a
vast understanding of the data model, so this was addressed by
adding the capability of storing queries for later use. This feature
allows an individual who is knowledgeable of caTissue’s object
model and the application’s functionality to create a ‘‘canned”
query for use by others. Furthermore, the ability to specify query
parameters was also added. To satisfy the need for researchers to
easily discover and access biospecimens without advanced under-
standing of the biobanking process or database structure, which
they were still unable to achieve, enhancements have been made
to the query functionality within the latest release of OpenSpeci-
men [18,19].
These changes were not only cosmetic but also in line with the
‘bigger picture’ of aiding user accessibility and discoverability
within and across applications by providing a lower learning curve.These enhancements in application approachability aid in export-
ing data from the application more readily to expedite research
and clinical efforts in addition to collaborative use of the data
across institutions. Such alterations to the application were in line
with an overall shift in development perspective and aim of
improving the user community’s ability to enter, access, track,
and share both their data and biospecimens more readily within
the application. This shift in development altered the focus of
OpenSpecimen as an application to store and track biospecimen
data to an application that can aid researchers in flexibly viewing
and exporting data across applications to thus offer a more robust
and malleable data resource.
Attaining such interoperability and bolstering of robust data
sources through integration across systems represents a further
developmental shift away from creating an exclusively unified
application aimed to be adopted as a single closed package.
Instead, aims are shifting toward an open application providing
flexible interoperability with diverse systems and plugins, a more
amenable interface and workflow, and freely available source-
code to spark adoption, further innovation, and expansion within
the biobanking community.
The inclusion of dynamic form extensions within caTissue Suite
has evolved and expanded into the ability to generate custom
forms within OpenSpecimen [20]. Through feedback from commu-
nity adopters, the ability to expand default specimen events and
collection procedures – such as freeze, spun, thaw – to adapt for
the inclusion of unique events for emerging research. Users may
create new dynamic events using the custom form builder and
make it available and queryable for all data entry for specimens
of all collection events. Thus, a research initiative need not sacrifice
accuracy and complexity of documentation within collected
biospecimen data to match default form values. Additional adapta-
tions to lessons learned and concerns reported by the community
include expansions of structured vocabulary to support SNOMED
coding of tissue anatomic site, in addition to enhancements to
encoding familial relationships and a streamlining of the ship-
ping/distribution workflow interface.
As we transition from an NCI supported initiative to an
open-source community driven initiative, we have also learned
that one needs an initial driver and form of governance to direct
L.D. McIntosh et al. / Journal of Biomedical Informatics 57 (2015) 456–464 463the trajectory of the application’s development. We currently oper-
ate under the direction of a beneficent oligarchy wherein a com-
munity board comprised of research technicians, biorepository
managers, application developers, research specialists, and data
scientists review the application enhancements proposed by users
within the End User Committee. End users are free to share their
day-to-day experiences in working with the application, thus pro-
viding to the community board insight into the needs and limita-
tions which need to be addressed. Users are also requested to
review and validate new features through group testing environ-
ments and mock screens. End users are further engaged through
monthly webinars, application demonstrations, and yearly face-
to-face meetings during which they can report questions, concerns,
or suggestions. Proposed enhancements and expansions are evalu-
ated for feasibility, overall efficacy, and the expected scale of com-
munity adoption during monthly phone calls between the
community board members. Approved enhancements are then
put into the development queue for build and testing.4. Discussion
OpenSpecimen is a freely available, open-access, web-based
software application allowing for the storage, inventory tracking,
annotation, and retrieval of biospecimen data from a relational
database. It permits biorepository resource staff to track the collec-
tion, storage, and distribution of biospecimens; monitor data and
biospecimens for quality assurance; as well as derive and aliquot
new biospecimens from existing ones (e.g. for nucleic acid analy-
sis). It may be used by biorepository facilities regardless of the nat-
ure of biospecimen transactions occurring or the type of
biospecimens involved in the transaction. Furthermore, research
scientists can search for and request biospecimens to be used in
translational studies.
As compared with other systems [21–24], OpenSpecimen
offers: developed, documented, and tested software using princi-
ples of commercial software development while remaining freely
available for a variety of biorepository environments and work-
flows; open and documented API leveraged for interoperation with
other systems; freely modifiable code base with documented
instructions; and, a large and growing academic and commercial
user community.
OpenSpecimen is developed and improved to satisfy continuous
feedback from its growing global user community. Currently, nine-
teen repositories are represented in OpenSpecimen within a single
database at Washington University School of Medicine, represent-
ing research in cancer, Alzheimer’s, gastro-intestinal (GI), renal,
cardiac and other disease groups. OpenSpecimen has been adopted
by more than forty academic and industry institutions in the US,
Australia, Europe, China and India including Washington Univer-
sity, Indiana University, Thomas Jefferson University, Yale Univer-
sity, Emory University, Louisiana Cancer Research Consortium
(LCRC), Oregon Health & Science University, University of New
South Wales, Vanderbilt University, and Cancer Research Center
of Hawaii, and Ohio University. Technical and end-user documen-
tation, training modules, discussion forums, FAQs, and application
updates for OpenSpecimen have been supported through the
Krishagni OpenSpecimen Support Center and community forum
[25–27]. More support information can be found on-line in
Appendix B.5. Conclusion
Use of the software in daily biorepository operations by several
NCI Cancer Centers and other biospecimen resource groups is
providing a rapid and facilitated path toward standardizingbiospecimen informatics and promoting biospecimen data sharing
both nationally and globally. OpenSpecimen is sufficiently scalable
and configurable for broad deployment across biorepositories of
varying size and function.
OpenSpecimen is a freely available, supported, open-access
software application for biobanking management systems, thus
providing the only known free and open-source biospecimen infor-
matics tool available. This has moved the biospecimen informatics
community forward through growing from an NCI directed initia-
tive to a community-based initiative to enhance biospecimen soft-
ware. The user community can work to clarify enhancement
requests, verify bugs, and prioritize fixes for inclusion in open
source development cycles. Community code contributions are
available for download and provide a way for developers to share
locally developed code with the broader community of users. As
we move forward with the Open Source Development Initiative
the biopecimen community will be more empowered to set direc-
tion and goals for future enhancements and other application
development.
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